(Q73712768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

CD143 in the development of atherosclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

R Metzger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R M Bohle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Chumachenko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S M Danilov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F E Franke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

21-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Cellular distribution of angiotensin-converting enzyme after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Activation of two angiotensin-generating systems in the balloon-injured artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Autoradiographic localization of angiotensin-converting enzyme and angiotensin II binding sites in early atheroma-like lesions in rabbit arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Increased concentrations of angiotensin-converting enzyme in the intimal hyperplasia of experimental vein grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Circulating and tissue angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Upregulation of Angiotensin-Converting Enzyme During the Healing Process After Injury at the Site of Percutaneous Transluminal Coronary Angioplasty in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Immunocytochemical analysis of the atherosclerotic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Angiotensin-converting enzyme in non-neoplastic kidney diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

The stability of angiotensin receptors and angiotensin converting enzyme in post mortem brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Functional heterogeneity of vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Differentiation of endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Studies on the histogenesis of myxomatous tissue of human coronary lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Membrane protein secretases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Elastin synthesis is inhibited by angiotensin II but not by platelet-derived growth factor in arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

Angiotensin-converting enzyme inhibitors in patients with coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900354-8

10.1016/S0021-9150(99)00354-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10781632%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference